rivn-202407240001874178FALSERivian Automotive, Inc. / DE00018741782024-07-242024-07-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
July 24, 2024
Date of Report (date of earliest event reported)
___________________________________
Rivian Automotive, Inc.
(Exact name of registrant as specified in its charter)
___________________________________
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
Delaware (State or other jurisdiction of incorporation) | 001-41042 (Commission File Number) | 47-3544981 (IRS Employer Identification Number) |
14600 Myford Road Irvine, California 92606 |
(Address of principal executive offices) (Zip code) |
(888) 748-4261 |
(Registrant's telephone number, including area code) |
N/A |
(Former name or former address, if changed since last report) |
___________________________________ |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | | | | | | | | | | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Securities registered pursuant to Section 12(b) of the Act: |
| | | | | | | | | |
| Title of each class | | Trading Symbol | | Name of each exchange on which registered |
| Class A common stock, $0.001 par value per share | | RIVN | | The Nasdaq Stock Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 24, 2024, Dr. Kjell Gruner, Chief Commercial Officer and President, Business Growth of Rivian Automotive, Inc. (the "Company"), notified the Company of his decision to resign to pursue other opportunities. Dr. Gruner’s last day as Chief Commercial Officer and President, Business Growth is July 26, 2024, and he will remain employed by the Company until February 17, 2025 to assist with the transition, as needed. Dagan Mishoulam, who has played an integral role at the Company for the past several years, is assuming the role of Senior Vice President, Commercial, and many of the responsibilities previously held by Dr. Gruner. Dr. Gruner’s resignation is not the result of any disagreement with the Company on any matters related to its business, policies, or practices.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
| |
| | |
| RIVIAN AUTOMOTIVE, INC. |
| | |
Date: July 26, 2024 | By: | /s/ Claire McDonough |
| Name: | Claire McDonough |
| Title: | Chief Financial Officer |
| | |